Lip filler migration, dissolving, and warning signs

Lip filler migration means material is suspected to have moved beyond the intended placement area, but swelling, product in an adjacent plane, overfilling, tissue change, nodules, and normal anatomy can look similar. Hyaluronidase may reduce hyaluronic-acid filler; it is not a universal eraser and is not FDA-approved specifically for aesthetic filler reversal.

“Migration” describes a proposed explanation, not a diagnosis that can be made from a social-media photo. Timing, palpation, the original injection map, product identity, and associated symptoms change the possibilities. The first decision is therefore not simply whether to dissolve; it is whether the finding is an expected contour issue, a delayed reaction, or a time-sensitive complication. ¹²

Name the finding before naming the cause

FDA lists migration among reported filler risks and warns that inadvertent injection into a blood vessel can cause tissue death, vision abnormalities or blindness, and stroke. Product identity matters because removal options differ by material.

A soft band above the vermilion border, a firm focal lump, generalized puffiness, and a new painful color change are not interchangeable presentations. Early swelling may obscure the injected contour. Later fullness can reflect the amount placed, its plane, persistent edema, preexisting anatomy, tissue response, or material outside the intended region. Nodules can have inflammatory, infectious, or product-related explanations that require a different response from an uncomplicated aesthetic revision.

Build a timeline before drawing conclusions. Record every filler date, brand, amount, area, injector, and whether prior dissolving or refilling occurred. Note when the contour first appeared and whether it changes during the day. Baseline and current photographs taken in comparable lighting can reveal whether the “new” shadow or projection existed before treatment.

What hyaluronidase can and cannot do

Appearance alone cannot establish where product sits or why a contour changed. Hyaluronidase activity varies with product, cross-linking, dose, location, time, and tissue. More than one session may be proposed, and loss of volume can be uneven or greater than intended.

Hyaluronidase breaks down hyaluronic acid, so it is relevant when the material is an HA filler. It does not dissolve calcium hydroxylapatite, poly-L-lactic acid, polymethylmethacrylate, silicone, scar tissue, or every cause of swelling. If the original product is unknown, retrieving the treatment record is more useful than assuming all lip filler is the same.

Aesthetic filler reversal is an off-label use of hyaluronidase products. The response can vary with the filler formulation and cross-linking, the age and location of the deposit, tissue access, enzyme product, dose, and technique. “One vial removes everything” and “only the migrated material will disappear” are both too certain. Partial response, uneven volume, repeated assessment, or more than one session may occur.

The endpoint should be specified before injecting the enzyme. Is the goal to reduce a discrete ridge, remove most known HA before a later plan, or respond to a suspected vascular event? The last situation is an emergency protocol, not a leisurely cosmetic dissolve appointment. Routine refilling should not be scheduled before the tissue response and revised anatomy can be reassessed.

Examination can change the plan

Inspection at rest and during animation can distinguish surface contour from muscle movement or shadow. Palpation can add information about firmness, tenderness, warmth, mobility, and fluctuation. When product location remains uncertain, an appropriately trained clinician may consider imaging such as high-frequency ultrasound if it is available and the result would change management. Imaging is not a substitute for urgent care when vascular or neurologic symptoms are present.

Product history also shapes whether dissolving is even logical. FDA’s filler overview separates temporary, longer-lasting, and permanent materials and notes that reduction or removal can be difficult or impossible, particularly for non-HA or permanent products. A clinic that proposes hyaluronidase should explain why it believes HA is present and what it will do if the contour does not respond.

Material risks and response planning

New severe or escalating pain, blanching or dusky discoloration, cool skin, visual symptoms, weakness, trouble speaking, or signs of severe allergy call for urgent escalation. Fever, spreading redness, drainage, or increasing warmth also need prompt clinical assessment.

Vascular compromise can evolve quickly. Severe or escalating pain, pale or blanched skin, dusky or netlike discoloration, cool tissue, delayed capillary refill, visual disturbance, eye pain, weakness, facial droop, or speech difficulty should trigger immediate professional assessment. Vision or neurologic symptoms warrant emergency escalation rather than messaging a clinic for routine advice. FDA identifies unintended injection into a blood vessel as the filler risk with the most serious potential consequences.

Fever, spreading redness, drainage, increasing warmth, marked tenderness, or rapidly worsening swelling can suggest infection or another inflammatory problem and also deserve prompt evaluation. Sudden lip, tongue, or throat swelling, trouble breathing, or signs of a severe allergic reaction require emergency care. A painless stable ridge weeks later belongs in a different lane, but it still merits examination before more product is layered over it.

Hyaluronidase brings its own risks, including local reactions and the possibility of hypersensitivity. The provider should identify the enzyme product, planned amount, treatment region, allergy history, observation plan, and after-hours contact. Documentation of the original filler and any dissolving session makes later reconstruction safer and more understandable.

Questions for a migration or dissolving visit

1. 1. What observed finding are you calling migration? Ask the clinician to describe location, feel, symmetry, timing, and alternative explanations without relying on the label alone.
2. 2. How certain are you about the filler material? Confirm the original brand from records when possible; hyaluronidase only addresses a hyaluronic-acid component.
3. 3. Would imaging alter this decision? If ultrasound is proposed, ask who performs it, what question it answers, and how each possible result changes treatment.
4. 4. What is the smallest useful dissolving endpoint? Define whether the aim is focal reduction, broad removal, or emergency management and how response will be judged.
5. 5. Which symptoms bypass a scheduled appointment? Get explicit instructions for pain, color change, visual or neurologic symptoms, infection signs, and severe allergy.
6. 6. How long will you wait before considering refill? Allow edema and contour to settle enough for a new baseline; avoid a prepaid dissolve-and-refill conveyor belt.

Separate correction from crisis care

Start with the original product name, dates, amounts, lots if available, and every area treated. Separate an aesthetic revision from an inflammatory problem or emergency. If dissolving is proposed, ask what diagnosis is being considered, why the filler is believed to be HA, and what follow-up is planned.

An elective contour correction allows time to retrieve records, compare photographs, examine the tissue, discuss off-label enzyme use, and stage conservative reassessment. A painful or discolored lip, visual symptom, neurologic change, or rapidly progressive reaction does not. That triage distinction is more important than deciding whether a photo resembles someone else’s “migration.”

For a stable aesthetic concern, define what would count as enough improvement and what nonresponse would mean. Repeated blind enzyme injections are not a substitute for reconsidering the material, diagnosis, or anatomy. Likewise, immediate refilling can recreate the same projection before the reason for it is understood.

The useful close is a documented one: original product, map, chronology, examination findings, reason for or against dissolving, urgent instructions, and a dated reassessment. That record turns an imprecise online term into a safer, testable plan without pretending to diagnose the appearance remotely.